Research priorities for global measles and rubella control and eradication

WHO Global Measles Rubella Laboratory Network Meeting

The WHO Global Measles and Rubella Laboratory Network performs a key role in measles and rubella surveillance by confirming suspected cases using standardized and validated testing and reporting procedures. The WHO Measles and Rubella Laboratory Network (LabNet) comprises 679 laboratories globally, almost all of which are following standardized testing and reporting procedures and undergo regul...

Horizontal transmission and measles vaccine: implications for neo-pathogenesis, measles control, and measles eradication

Measles, mumps, and rubella.

Measles, mumps, and rubella are viral diseases that may adversely affect nonimmune pregnant women and their fetuses/neonates. Prevention of these diseases and their complications can be achieved through measles-mumps-rubella (MMR) vaccination before pregnancy. The vaccine is contraindicated during pregnancy, because it contains live, attenuated viruses that pose a theoretical risk to the fetus....

Measles and Rubella Global Strategic Plan 2012-2020 midterm review.

KEY HIGHLIGHTS 1. Measles eradication is the ultimate goal but it is premature to set a date for its accomplishment. Existing regional elimination goals should be vigorously pursued to enable setting a global target by 2020. 2. The basic strategic approaches articulated in the Global Measles and Rubella Strategic Plan 2012-2020 are valid to achieve the goals but have not been fully implemented ...

Global eradication of measles: an epidemiologic and economic evaluation.

BACKGROUND Measles remains an important cause of morbidity and mortality in children in developing countries. Due to the success of the measles mortality reduction and elimination efforts thus far, the WHO has raised the question of whether global eradication of measles is economically feasible. METHODS The cost-effectiveness of various measles mortality reduction and eradication scenarios wa...